Author Archives: wames
Potential role of microbiome in CFS/ME
Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME), by Guiseppe Lupo. PhD thesis, Università Cattolica del Sacro Cuore, XXXII ciclo, a.a. 2018/19, Piacenza, 8 April 2020 Research abstract: The Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME), is a severe multisystemic … Continue reading
Unravelling ME/CFS: Gender‐specific changes in the microRNA expression profiling in ME/CFS
Unravelling ME/CFS: Gender‐specific changes in the microRNA expression profiling in ME/CFS by Amanpreet K Cheema, Leonor Sarria, Mina Bekheit, Fanny Collado, Eloy Almenar‐Pérez, Eva Martín‐Martínez, Jose Alegre, Jesus Castro‐Marrero, Mary A Fletcher, Nancy G Klimas, Elisa Oltra, Lubov Nathanson in … Continue reading
Autoimmunity-related risk variants in PTPN22 & CTLA4 are associated with ME/CFS with infectious onset
Autoimmunity-related risk variants in PTPN22 and CTLA4 are associated with ME/CFS with infectious onset, by Sophie Steiner, Sonya C Becker, Jelka Hartwig, Franziska Sotzny, Sebastian Lorenz, Sandra Bauer, Madlen Löbel, Anna B Stittrich, Patricia Grabowski and Carmen Scheibenbogen in Front. Immunol., … Continue reading
Processing of Laser-Evoked Potentials in patients with Chronic Whiplash-Associated Disorders, CFS & healthy controls: a case–control study
Processing of Laser-Evoked Potentials in patients with Chronic Whiplash-Associated Disorders, Chronic Fatigue Syndrome, and healthy controls: a case–control study, by Lisa Goudman, PhD, Liesbeth Daenen, PhD, Andre Mouraux, PhD, Jo Nijs, PhD, Patrick Cras, PhD, Nathalie Roussel, PhD, Maarten Moens, … Continue reading
Opposition to Oxford NHS Trust leaflet which confuses post Covid-19 fatigue with ME/CFS
The ME community requests Oxford NHS Trust leaflet be withdrawn A collection of physicians, physiotherapists MPs and patient charities have written to Oxford Health NHS Foundation Trust to object to the content of a leaflet by their Psychosocial Response … Continue reading
MCP-1 is increased in patients with CFS & FM, whilst several other immune markers are significantly lower than healthy controls
MCP-1 is increased in patients with CFS and FM, whilst several other immune markers are significantly lower than healthy controls, by Nina Groven, Egil Andreas Fors, Astrid Kamilla Stunes, Solveig Klæbo Reitan in Brain, Behavior, & Immunity – Health Vol … Continue reading
A unifying hypothesis of the pathophysiology of ME/CFS: recognitions from the finding of autoantibodies against ß2-adrenergic receptors
A unifying hypothesis of the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): recognitions from the finding of autoantibodies against ß2-adrenergic receptors, by Klaus Wirth, Carmen Scheibenbogen in Autoimmunity Reviews, online 1 April 2020 [doi.org/10.1016/j.autrev.2020.102527] Research abstract: Myalgic Encephalomyelitis or Chronic … Continue reading
CFS – what nurses need to know (US)
Chronic Fatigue Syndrome – what nurses need to know, by Marianne Bush BS, RN in Nursing April 2020, vol 50 no. 4 – pp50-54 [doi:10.1097/01.NURSE.0000657068.67389.47] Author information: Marianne Bush is an RN contractor for a national wellness company. Article abstract: … Continue reading
The effect of ME/CFS severity on cellular bioenergetic function
The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function, by Cara Tomas, Joanna L Elson, Victoria Strassheim, Julia L Newton, Mark Walker in PLoS One vol 15, #4, e0231136, April 10, 2020 Research abstract: Myalgic … Continue reading
